Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning

Journal of Neuroscience Research

Volumn 88, Issue 14, 2010, Pages 3180-3188

  Chen, Zhi Yong ^a,b   Wang, Li ^a   Asavaritkrai, Pundit ^c   Noguchi, Constance Tom ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Mahidol University ^*  (Thailand)

Author keywords

Erythropoietin; Hypoxia; Neuroprotection; Nitric oxide; Receptor expression

Indexed keywords

ERYTHROPOIETIN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DONOR; EMBRYO; ENZYME ACTIVITY; HYPOXIA; MOUSE; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYTOPROTECTION; ERYTHROPOIETIN, RECOMBINANT; GENE EXPRESSION REGULATION; HYPOXIA-ISCHEMIA, BRAIN; ISCHEMIC PRECONDITIONING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; NITRIC OXIDE; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78149304438     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22473     Document Type: Article

References (40)

1. Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. 2004. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104: 2073-2080.
2. Bishop A, Anderson JE. 2005. NO signaling in the CNS: from the physiological to the pathological. Toxicology 208: 193-205.
3. Cazzola M. 2004. Erythropoietin pathophysiology and erythropoietin deficiency anemia. Hematol J 5(Suppl 3): S100-S103.
4. Chavez JC, Baranova O, Lin J, Pichiule P. 2006. The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26: 9471-9481.
5. Chen ZY, Asavaritikrai P, Prchal JT, Noguchi CT. 2007. Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J Biol Chem 282: 25875-25883.
6. Chin K, Oda N, Shen K, Noguchi CT. 1995. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res 23: 3041-49.
7. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. 2001. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282: 1075-1079.
8. Cramer SC, Fitzpatrick C, Warren M, Hill MD, Brown D, Whitaker L, Ryckborst KJ, Plon L, 2010. The Beta-hCG+Erythropoietin in Acute Stroke (BETAS) Study: A 3-Center, Single-Dose, Open-Label, Noncontrolled, Phase IIa Safty Trail. Stroke 41: 927.
9. Dame C, Juul SE, Christensen RD. 2001. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate 79: 228-235.
10. Dawson TM. 2002. Preconditioning-mediated neuroprotection through erythropoietin? Lancet 359: 96-97.
11. Digicaylioglu M, Lipton SA. 2001. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647.
12. Divoky V, Liu Z, Ryan TM, Prchal JF, Townes TM, Prchal JT. 2001. Mouse model of congenital polycythemia: Homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proc Natl Acad Sci U S A 98: 986-991.
13. Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Buhrer C, Ikonomidou C, Hansen HH. 2004. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15: 177-187.
14. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Sirén AL. 2002. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8: 495-505.
15. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimer C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C. 2009. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40: e647-e656.
16. Elliott S, Busse L, Bass MB, Lu H, Sarosi I, Sinclair AM, Spahr C, Um M, Van G, Begley CG. 2006. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107: 1892-1895.
17. Gassmann M, Heinicke K, Soliz J, Ogunshola OO, Marti HH, Hofer T, Grimm C, Heinicke I, Egli B. 2003. Non-erythroid functions of erythropoietin. Adv Exp Med Biol 543: 323-330.
18. Genc S, Kuralay F, Genc K, Akhisaroglu M, Fadiloglu S, Yorukoglu K, Fadiloglu M, Gure A. 2001. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 298: 139-141.
19. Genc S, Koroglu TF, Genc K. 2004. Erythropoietin as a novel neuroprotectant. Restor Neurol Neurosci 22: 105-119.
20. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE. 2002. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8: 718-724.
21. Grimm C, Wenzel A, Stanescu D, Samardzija M, Hotop S, Groszer M, Naash M, Gassmann M, Reme C. 2004. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 24: 5651-5658.
22. Huang PL. 2004. Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 36: 323-329.
23. Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G, Bonavida B. 2004. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Oncogene 23: 4993-5003.
24. Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K, Elango C, Singh AK, Singh I. 2005. S-nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab 25: 177-192.
25. Knabe W, Knerlich F, Washausen S, Kietzmann T, Sirén AL, Brunnett G, Kuhn HJ, Ehrenreich H. 2004. Expression patterns of erythropoietin and its receptor in the developing midbrain. Anat Embryol 207: 503-512.
26. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. 2001. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med 193: 741-754.
27. Liu C, Yu K, Shen K, Liu Z, Noguchi CT. 1996. Transgenic mice containing the human erythropoietin receptor gene exhibit correct hematopoietic and neural expression. Proc Assoc Am Physicians 108: 449-454.
28. Liu ZY, Chin K, Noguchi CT. 1994. Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 166: 159-169.
29. Marti HH. 2004. Erythropoietin and the hypoxic brain. J Exp Biol 207: 3233-3242.
30. Marti HH, Gassmann M, Wenger RH, Kvietikova I, Morganti-Kossmann MC, Kossmann T, Trentz O, Bauer C. 1997. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 51: 416-418.
31. Ogilvie M, Yu X, Nicolas-Metral V, Pulido SM, Liu C, Ruegg UT, Noguchi CT. 2000. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 275: 39754-39761.
32. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A. 2002. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22: 10291-10301.
33. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. 1998. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95: 4635-4640.
34. Shingo T, Sorokan ST, Shimazaki T, Weiss S. 2001. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21: 9733-9743.
35. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. 2001. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044-4049.
36. Suzuki N, Ohneda O, Takahashi S, Higuchi M, Mukai HY, Nakahata T, Imagawa S, Yamamoto M. 2002. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality. Blood 100: 2279-2288.
37. Winkelmann JC. 1992. The human erythropoietin receptor. Int J Cell Cloning 10: 254-261.
38. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT. 2002. Erythropoietin receptor signalling is required for normal brain development. Development 129: 505-516.
39. Zemke D, Smith JL, Reeves MJ, Majid A. 2004. Ischemia and ischemic tolerance in the brain: an overview. Neurotoxicology 25: 895-904.
40. Zhou J, Brune B. 2005. NO and transcriptional regulation: from signaling to death. Toxicology 208: 223-233.